Home/Filings/4/0001178913-22-001387
4//SEC Filing

Galitzer Hillel 4

Accession 0001178913-22-001387

CIK 0001638097other

Filed

Apr 3, 8:00 PM ET

Accepted

Apr 4, 4:05 PM ET

Size

5.5 KB

Accession

0001178913-22-001387

Insider Transaction Report

Form 4
Period: 2022-03-31
Galitzer Hillel
Chief Operating Officer
Transactions
  • Award

    Stock Option (right to buy)

    2022-03-31+60,00060,000 total
    Exercise: $2.86Exp: 2032-03-31Ordinary Shares, par value NIS 0.0000769 per share (60,000 underlying)
Footnotes (1)
  • [F1]The options vest over a four-year period that commenced on March 31, 2022, with 25% of the options vesting on the first anniversary of the vesting commencement date. The remaining options vest ratably on a quarterly basis over the remaining three-year period.

Documents

1 file

Issuer

Entera Bio Ltd.

CIK 0001638097

Entity typeother

Related Parties

1
  • filerCIK 0001904740

Filing Metadata

Form type
4
Filed
Apr 3, 8:00 PM ET
Accepted
Apr 4, 4:05 PM ET
Size
5.5 KB